Table 2 Lung function results and respiratory morbidity.
| Symptomatic RSV LRTI group | Controls | p value | |
|---|---|---|---|
| (n = 15) | (n = 24) | ||
| Lung function | |||
| Postmenstrual age (wk) | 35.8 (0.6) | 35.9 (0.5) | 0.89 |
| Weight (kg) | 2.13 (0.38) | 2.38 (0.46) | 0.17 |
| FRC (ml/kg) | 21.9 (4.2) | 21.6 (3.4) | 0.94 |
| Crs (ml/cm H2O/kg) | 0.98 (0.47) | 0.99 (0.52) | 0.82 |
| Rrs (cm H2O/l/s) | 126.1 (62.1) | 89.1 (27.8) | 0.01 |
| Respiratory morbidity at one year | |||
| Cough (days/month) | 7 (0–31) | 3 (0–14) | 0.06 |
| Wheeze (days/month) | 5 (0–22) | 0 (0–7) | 0.04 |
Data are shown as mean (standard deviation), or median (range).